{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T10:39:36Z","timestamp":1789727976532,"version":"4.0.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s11060-024-04862-5","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T16:02:40Z","timestamp":1731600160000},"page":"413-421","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Serum lactate dehydrogenase as a prognostic marker for treatment response in IDH wild-type glioblastoma patients undergoing stupp protocol"],"prefix":"10.1007","volume":"171","author":[{"given":"Paolo","family":"Tini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Cinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariya","family":"Yavorska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Donnini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Marampon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierpaolo","family":"Pastina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Chibbaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Cerase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Antonietta","family":"Mazzei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Di Giacomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Minniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"4862_CR1","doi-asserted-by":"crossref","unstructured":"Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. 352(10):987\u2013996","DOI":"10.1056\/NEJMoa043330"},{"issue":"7","key":"4862_CR2","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1093\/neuonc\/noad038","volume":"25","author":"M Weller","year":"2023","unstructured":"Weller M, Le Rhun E, Van den Bent M, Chang SM, Cloughesy TF, Goldbrunner R, Hong YK, Jalali R, Jenkinson MD, Minniti G, Nagane M, Razis E, Roth P, Rud\u00e0 R, Tabatabai G, Wen PY, Short SC, Preusser M (2023) Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults. Neuro Oncol 25(7):1200\u20131224. https:\/\/doi.org\/10.1093\/neuonc\/noad038","journal-title":"Neuro Oncol"},{"key":"4862_CR3","doi-asserted-by":"publisher","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell. 144(5):646\u2013\u200974. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"4862_CR4","doi-asserted-by":"publisher","first-page":"9800","DOI":"10.1038\/srep09800","volume":"5","author":"J Zhang","year":"2015","unstructured":"Zhang J, Yao YH, Li BG, Yang Q, Zhang PY, Wang HT (2015) Prognostic value of pretreatment serum lactate dehydrogenase level in patients with solid tumors: a systematic review and meta-analysis. Sci Rep 5:9800. https:\/\/doi.org\/10.1038\/srep09800","journal-title":"Sci Rep"},{"key":"4862_CR5","doi-asserted-by":"publisher","unstructured":"Petrelli F, Ardito R, Merelli B, Lonati V, Cabiddu M, Seghezzi S, Barni S, Ghidini A (2019) Prognostic and predictive role of elevated lactate dehydrogenase in patients with melanoma treated with immunotherapy and BRAF inhibitors: a systematic review and meta-analysis. Melanoma Res. 29(1):1\u201312. https:\/\/doi.org\/10.1097\/CMR.0000000000000520","DOI":"10.1097\/CMR.0000000000000520"},{"issue":"1","key":"4862_CR6","doi-asserted-by":"publisher","first-page":"2293514","DOI":"10.1080\/16078454.2023.2293514","volume":"29","author":"W Wu","year":"2024","unstructured":"Wu W, Miao L, Zhao L, Zhu Y, Mao J, Cai Z, Ji Y, Wang L, Wang Y, Jia T (2024) Prognostic value of lactate dehydrogenase, serum albumin and the lactate dehydrogenase\/albumin ratio in patients with diffuse large B-cell lymphoma. Hematology 29(1):2293514. https:\/\/doi.org\/10.1080\/16078454.2023.2293514","journal-title":"Hematology"},{"issue":"32","key":"4862_CR7","doi-asserted-by":"publisher","first-page":"9825","DOI":"10.12998\/wjcc.v9.i32.9825","volume":"9","author":"XB Wu","year":"2021","unstructured":"Wu XB, Hou SL, Liu H (2021) Systemic immune inflammation index, ratio of lymphocytes to monocytes, lactate dehydrogenase and prognosis of diffuse large B-cell lymphoma patients. World J Clin Cases 9(32):9825\u20139834. https:\/\/doi.org\/10.12998\/wjcc.v9.i32.9825","journal-title":"World J Clin Cases"},{"issue":"8","key":"4862_CR8","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/cncr.34113","volume":"128","author":"A Tjokrowidjaja","year":"2022","unstructured":"Tjokrowidjaja A, Lord SJ, John T, Lewis CR, Kok PS, Marschner IC, Lee CK (2022) Pre- and on-treatment lactate dehydrogenase as a prognostic and predictive biomarker in advanced non-small cell lung cancer. Cancer 128(8):1574\u20131583. https:\/\/doi.org\/10.1002\/cncr.34113","journal-title":"Cancer"},{"issue":"4","key":"4862_CR9","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1002\/cam4.2024","volume":"8","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Li Y, Yan X, Song Q, Wang G, Hu Y, Jiao S, Wang J (2019) Pretreatment lactate dehydrogenase may predict outcome of advanced non small-cell lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis. Cancer Med 8(4):1467\u20131473. https:\/\/doi.org\/10.1002\/cam4.2024","journal-title":"Cancer Med"},{"issue":"7","key":"4862_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.trecan.2016.06.002","volume":"2","author":"A Nagarajan","year":"2016","unstructured":"Nagarajan A, Malvi P, Wajapeyee N (2016) Oncogene-directed alterations in cancer cell metabolism. Trends Cancer 2(7):365\u2013377. https:\/\/doi.org\/10.1016\/j.trecan.2016.06.002","journal-title":"Trends Cancer"},{"issue":"12","key":"4862_CR11","doi-asserted-by":"publisher","first-page":"6124","DOI":"10.1002\/cam4.1820","volume":"7","author":"Y Feng","year":"2018","unstructured":"Feng Y, Xiong Y, Qiao T, Li X, Jia L, Han Y (2018) Lactate dehydrogenase A: a key player in carcinogenesis and potential target in cancer therapy. Cancer Med 7(12):6124\u20136136. https:\/\/doi.org\/10.1002\/cam4.1820","journal-title":"Cancer Med"},{"issue":"1","key":"4862_CR12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","volume":"17","author":"RG Verhaak","year":"2010","unstructured":"Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O\u2019Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, Getz G, Perou CM, Hayes DN (2010) Cancer Genome Atlas Research Network. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17(1):98\u2013110. https:\/\/doi.org\/10.1016\/j.ccr.2009.12.020","journal-title":"Cancer Cell"},{"issue":"16","key":"4862_CR13","doi-asserted-by":"publisher","first-page":"8835","DOI":"10.3390\/ijms23168835","volume":"23","author":"H Sareen","year":"2022","unstructured":"Sareen H, Ma Y, Becker TM, Roberts TL, de Souza P, Powter B (2022) Molecular biomarkers in Glioblastoma: a systematic review and Meta-analysis. Int J Mol Sci 23(16):8835. https:\/\/doi.org\/10.3390\/ijms23168835","journal-title":"Int J Mol Sci"},{"issue":"11","key":"4862_CR14","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1200\/JCO.2009.26.3541","volume":"28","author":"PY Wen","year":"2010","unstructured":"Wen PY, Macdonald DR, Reardon DA, Cloughesy TF, Sorensen AG, Galanis E, Degroot J, Wick W, Gilbert MR, Lassman AB, Tsien C, Mikkelsen T, Wong ET, Chamberlain MC, Stupp R, Lamborn KR, Vogelbaum MA, van den Bent MJ, Chang SM (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28(11):1963\u20131972. https:\/\/doi.org\/10.1200\/JCO.2009.26.3541","journal-title":"J Clin Oncol"},{"issue":"2","key":"4862_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s13311-016-0507-6","volume":"14","author":"BM Ellingson","year":"2017","unstructured":"Ellingson BM, Wen PY, Cloughesy TF (2017) Modified Criteria for Radiographic Response Assessment in Glioblastoma clinical trials. Neurotherapeutics 14(2):307\u2013320. https:\/\/doi.org\/10.1007\/s13311-016-0507-6","journal-title":"Neurotherapeutics"},{"key":"4862_CR16","doi-asserted-by":"publisher","unstructured":"Koukourakis MI, Giatromanolaki A, Simopoulos C, Polychronidis A, Sivridis E (2005) Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer. Clin Exp Metastasis. 22(1):25\u201330. https:\/\/doi.org\/10.1007\/s10585-005-2343-7","DOI":"10.1007\/s10585-005-2343-7"},{"key":"4862_CR17","doi-asserted-by":"publisher","unstructured":"Cairns RA, Harris IS, Mak TW (2011) Regulation of cancer cell metabolism. Nat Rev Cancer. 11(2):85\u201395. https:\/\/doi.org\/10.1038\/nrc2981","DOI":"10.1038\/nrc2981"},{"issue":"2","key":"4862_CR18","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/carcin\/bgw127","volume":"38","author":"I San-Mill\u00e1n","year":"2017","unstructured":"San-Mill\u00e1n I, Brooks GA (2017) Reexamining cancer metabolism: lactate production for carcinogenesis could be the purpose and explanation of the Warburg Effect. Carcinogenesis 38(2):119\u2013133. https:\/\/doi.org\/10.1093\/carcin\/bgw127","journal-title":"Carcinogenesis"},{"key":"4862_CR19","doi-asserted-by":"publisher","first-page":"869307","DOI":"10.3389\/fimmu.2022.869307","volume":"13","author":"N Chen","year":"2022","unstructured":"Chen N, Peng C, Li D (2022) Epigenetic underpinnings of inflammation: a Key to unlock the Tumor Microenvironment in Glioblastoma. Front Immunol 13:869307. https:\/\/doi.org\/10.3389\/fimmu.2022.869307","journal-title":"Front Immunol"},{"issue":"1","key":"4862_CR20","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/s41392-020-00344-y","volume":"5","author":"Z Lu","year":"2020","unstructured":"Lu Z et al (2020) Lactate dehydrogenase promotes the polarization of tumor-associated macrophages toward the M2 phenotype via the HIF-1\u03b1 pathway in glioblastoma. Signal Transduct Target Therapy 5(1):226","journal-title":"Signal Transduct Target Therapy"},{"issue":"5","key":"4862_CR21","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/sj.bjc.6601205","volume":"89","author":"MI Koukourakis","year":"2003","unstructured":"Koukourakis MI, Giatromanolaki A, Sivridis E, Bougioukas G, Didilis V, Gatter KC, Harris AL, Tumour and Angiogenesis Research Group (2003) Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis. Br J Cancer 89(5):877\u2013885. https:\/\/doi.org\/10.1038\/sj.bjc.6601205","journal-title":"Br J Cancer"},{"key":"4862_CR22","doi-asserted-by":"publisher","unstructured":"Fantin VR, St-Pierre J, Leder P (2006) Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell. 9(6):425\u2013\u200934. https:\/\/doi.org\/10.1016\/j.ccr.2006.04.023. Erratum in: Cancer Cell. 2006;10(2):172","DOI":"10.1016\/j.ccr.2006.04.023"},{"issue":"1","key":"4862_CR23","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41392-020-00280-x","volume":"5","author":"MZ Jin","year":"2020","unstructured":"Jin MZ, Jin WL (2020) The updated landscape of tumor microenvironment and drug repurposing. Signal Transduct Target Ther 5(1):166. https:\/\/doi.org\/10.1038\/s41392-020-00280-x","journal-title":"Signal Transduct Target Ther"},{"key":"4862_CR24","doi-asserted-by":"publisher","first-page":"752404","DOI":"10.3389\/fmolb.2021.752404","volume":"8","author":"KM Stanke","year":"2021","unstructured":"Stanke KM, Wilson C, Kidambi S (2021) High expression of glycolytic genes in clinical glioblastoma patients correlates with Lower Survival. Front Mol Biosci 8:752404. https:\/\/doi.org\/10.3389\/fmolb.2021.752404","journal-title":"Front Mol Biosci"},{"issue":"11","key":"4862_CR25","doi-asserted-by":"publisher","first-page":"9137","DOI":"10.3390\/ijms24119137","volume":"24","author":"C Bernhard","year":"2023","unstructured":"Bernhard C, Reita D, Martin S, Entz-Werle N, Dontenwill M (2023) Glioblastoma metabolism: insights and therapeutic strategies. Int J Mol Sci 24(11):9137. https:\/\/doi.org\/10.3390\/ijms24119137","journal-title":"Int J Mol Sci"},{"key":"4862_CR26","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.3389\/fonc.2019.01143","volume":"9","author":"KG de la Cruz-L\u00f3pez","year":"2019","unstructured":"de la Cruz-L\u00f3pez KG, Castro-Mu\u00f1oz LJ, Reyes-Hern\u00e1ndez DO, Garc\u00eda-Carranc\u00e1 A, Manzo-Merino J (2019) Lactate in the regulation of Tumor Microenvironment and therapeutic approaches. Front Oncol 9:1143. https:\/\/doi.org\/10.3389\/fonc.2019.01143","journal-title":"Front Oncol"},{"issue":"1","key":"4862_CR27","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1038\/s41467-024-46193-z","volume":"15","author":"F Khan","year":"2024","unstructured":"Khan F, Lin Y, Ali H, Pang L, Dunterman M, Hsu WH, Frenis K, Grant Rowe R, Wainwright DA, McCortney K, Billingham LK, Miska J, Horbinski C, Lesniak MS, Chen P (2024) Lactate dehydrogenase a regulates tumor-macrophage symbiosis to promote glioblastoma progression. Nat Commun 15(1):1987. https:\/\/doi.org\/10.1038\/s41467-024-46193-z","journal-title":"Nat Commun"},{"issue":"5","key":"4862_CR28","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","volume":"24","author":"A Brand","year":"2016","unstructured":"Brand A, Singer K, Koehl GE, Kolitzus M, Schoenhammer G, Thiel A, Matos C, Bruss C, Klobuch S, Peter K, Kastenberger M, Bogdan C, Schleicher U, Mackensen A, Ullrich E, Fichtner-Feigl S, Kesselring R, Mack M, Ritter U, Schmid M, Blank C, Dettmer K, Oefner PJ, Hoffmann P, Walenta S, Geissler EK, Pouyssegur J, Villunger A, Steven A, Seliger B, Schreml S, Haferkamp S, Kohl E, Karrer S, Berneburg M, Herr W, Mueller-Klieser W, Renner K, Kreutz M (2016) LDHA-Associated Lactic Acid Production blunts Tumor Immunosurveillance by T and NK Cells. Cell Metab 24(5):657\u2013671. https:\/\/doi.org\/10.1016\/j.cmet.2016.08.011","journal-title":"Cell Metab"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04862-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-024-04862-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-024-04862-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:08:21Z","timestamp":1735862901000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-024-04862-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["4862"],"URL":"https:\/\/doi.org\/10.1007\/s11060-024-04862-5","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]},"assertion":[{"value":"28 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}